Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05085327 · ClinicalTrials.gov registry record · NA
Clinical Study to Evaluate the Sun Protection Factor (SPF) of Sunscreen Products
A NA study, sponsored by HALEON.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT05085327: Completed NA study, sponsored by HALEON.
NCT05085327 is a NA study that has completed, run by HALEON. The registered enrollment target is 11 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05085327, a NA study, has completed, sponsored by HALEON.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the static SPF of three sunscreen products (ChapStick Lip Moisturizer \[CLM\] Original, CLM Mint Flavour and CLM Black Cherry Flavour) using the methodology described in the Food and Drug Administration (FDA) Final Rule (2011).
Primary Outcome
SPF values for each test product and the SPF standard were first calculated for each individual participant: SPFi = MEDp/MEDuR (p=protected \[treated\] site; u=unprotected \[untreated\] site). The arithmetic mean SPF, standard deviation (SD) and standard error (SE) were then calculated separately for each test product and the SPF standard from valid SPFi data: SPF = (∑SPFi)/n; SD = √\[(∑SPFi\^2) - ((∑SPFi)\^2/n) / (n-1))\]; SE = SD/√n (n = no. participants providing valid test results). For SPF
Interventions
- DRUG SPF Standard Sunscreen
- DRUG ChapStick Lip Moisturizer Original
- DRUG ChapStick Lip Moisturizer Mint
- DRUG ChapStick Lip Moisturizer Black Cherry
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2021-10-19 |
| Est. Completion | 2021-11-04 |
| Phase | NA |
What the finished NCT05085327 record still lists
NCT05085327 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 4 interventions - of which SPF Standard Sunscreen is the first listed.
NCT05085327 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05085327 about?
NCT05085327 is a clinical study titled "Clinical Study to Evaluate the Sun Protection Factor (SPF) of Sunscreen Products". The purpose of this study is to determine the static SPF of three sunscreen products (ChapStick Lip Moisturizer \[CLM\] Original, CLM Mint Flavour and CLM Black Cherry Flavour) using the methodology described in the Food and Drug Administration (FDA) Final Rule (2011).
What is the current status of trial NCT05085327?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2021-10-19. Estimated completion is 2021-11-04.
What interventions are being tested in trial NCT05085327?
The interventions under investigation include: SPF Standard Sunscreen (DRUG), ChapStick Lip Moisturizer Original (DRUG), ChapStick Lip Moisturizer Mint (DRUG), ChapStick Lip Moisturizer Black Cherry (DRUG).
Who is sponsoring clinical trial NCT05085327?
This trial is sponsored by HALEON, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05085327's enrollment target sits among peer trials
11 1927th of 2000 higher than 74 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI